TY - JOUR
T1 - Post-transplant complications, patient, and graft survival in pediatric and adolescent kidney transplant recipients at a tropical tertiary care center across two immunosuppression eras
AU - Mohapatra, Anjali
AU - Valson, Anna T.
AU - Annapandian, Vellaichamy M.
AU - David, Vinoi George
AU - Alexander, Suceena
AU - Jacob, Shibu
AU - Kakde, Shailesh
AU - Kumar, Santosh
AU - Devasia, Antony
AU - Vijayakumar, Theophilus S.
AU - Tamilarasi, Veerasamy
AU - Jacob, Chakko Korula
AU - Basu, Gopal
AU - John, George Tharayil
AU - Varughese, Santosh
PY - 2021/9
Y1 - 2021/9
N2 - Background: We report pediatric PAKT patient and graft outcomes at a large tropical tertiary center spanning two transplant eras. Methods: In this retrospective cohort study, all children ≤18 years who underwent kidney transplantation at our center between 1991 and 2016 were included. Data pertaining to their baseline characteristics, post-transplant events, and outcome were retrieved from transplant records and compared between transplant eras (1991-2005 and 2006-2016). Results: A total of 139 children (mean age 15.2 ± 2.9 years) underwent PAKT during this period. The incidence of UTIs, CMV disease, BKVN, invasive fungal infections, new-onset diabetes after transplant, leucopenia, and recurrent NKD was higher in the 2006-2016 era (P <.001 for all), while 1-year cumulative BPAR was comparable (P =.100). Five-year graft and patient survival in the two eras were 89.9% and 94.2% (P =.365) and 92.1% and 95.3% (P =.739), respectively. Incidence of CMV disease, BKVN, graft loss, and death was lower in the calcineurin withdrawal group. Non-adherence accounted for 36% of graft loss; infections caused 43.7% of deaths. On multivariate Cox proportional hazards analysis, independent predictors for graft loss were UTIs and blood transfusion naïve status and for death were serious infections and glomerular NKD. Conclusions: PAKT in India has excellent long-term graft outcomes, though patient outcomes remain suboptimal owing to a high burden of infections. Current immunosuppression protocols need to be re-examined to balance infection risk, graft, and patient survival.
AB - Background: We report pediatric PAKT patient and graft outcomes at a large tropical tertiary center spanning two transplant eras. Methods: In this retrospective cohort study, all children ≤18 years who underwent kidney transplantation at our center between 1991 and 2016 were included. Data pertaining to their baseline characteristics, post-transplant events, and outcome were retrieved from transplant records and compared between transplant eras (1991-2005 and 2006-2016). Results: A total of 139 children (mean age 15.2 ± 2.9 years) underwent PAKT during this period. The incidence of UTIs, CMV disease, BKVN, invasive fungal infections, new-onset diabetes after transplant, leucopenia, and recurrent NKD was higher in the 2006-2016 era (P <.001 for all), while 1-year cumulative BPAR was comparable (P =.100). Five-year graft and patient survival in the two eras were 89.9% and 94.2% (P =.365) and 92.1% and 95.3% (P =.739), respectively. Incidence of CMV disease, BKVN, graft loss, and death was lower in the calcineurin withdrawal group. Non-adherence accounted for 36% of graft loss; infections caused 43.7% of deaths. On multivariate Cox proportional hazards analysis, independent predictors for graft loss were UTIs and blood transfusion naïve status and for death were serious infections and glomerular NKD. Conclusions: PAKT in India has excellent long-term graft outcomes, though patient outcomes remain suboptimal owing to a high burden of infections. Current immunosuppression protocols need to be re-examined to balance infection risk, graft, and patient survival.
KW - adolescent
KW - graft survival
KW - India
KW - kidney transplantation
KW - pediatric
KW - survival rate
UR - http://www.scopus.com/inward/record.url?scp=85100138686&partnerID=8YFLogxK
U2 - 10.1111/petr.13973
DO - 10.1111/petr.13973
M3 - Article
C2 - 33463876
AN - SCOPUS:85100138686
SN - 1397-3142
VL - 25
JO - Pediatric Transplantation
JF - Pediatric Transplantation
IS - 6
M1 - e13973
ER -